The research journal
News
Reports
Portraits
Reportages
Videos
Events
Press documents
|

Filter press documents

Make it Iconic, Choose France - Eiffel Tower
Press release
08.11.2024
The new face of “MAKE IT ICONIC. Choose France”, Professor Yasmine Belkaid embodies French boldness in the Government's international campaign
Professor Yasmine Belkaid, immunologist and President of the Institut Pasteur, has joined the international...
Dépression : un dysfonctionnement de certains neurones de l’amygdale serait à l’origine de la perception négative de l’environnement
Press release
24.10.2024
Depression: dysfunction of neurons in the amygdala may be behind negative perceptions of the environment
One of the characteristics of depression is a tendency to perceive sensory stimuli and everyday situations in an...
dépressionneurology neuronamygdala
Press Info
24.10.2024
Evaluating the link between chemicals and declining insect populations
Using a library of more than 1,000 agrochemicals, scientists saw significant changes in behaviour and long-term...
Immunothérapies des cancers du sang : mise en évidence de la destruction à distance des cellules cancéreuses
Press release
02.06.2023
Immunotherapy for blood cancer: remote destruction of tumor cells demonstrated
The aim of immunotherapy strategies is to use cells in the patient's own immune system to destroy tumor cells. CAR T...
cancerimmunotherapycar-t
Press release
29.03.2023
World Autism Awareness Day: Institut Pasteur working actively with clinicians and the autism community
As we mark World Autism Awareness Day on Sunday April 2, 2023, this year the Institut Pasteur is celebrating the 20th...
autisme
Emergence en France d’une souche de Shigella sonnei hautement résistante aux antibiotiques
Press release
15.03.2023
Emergence of extensively drug-resistant Shigella sonnei strain in France
Shigellosis, a highly contagious diarrheal disease, is caused by Shigella bacteria circulating in industrializing...
shigelladrug-resistantstisexually transmitted infections
Nouvelle étape franchie dans le développement d’un vaccin efficace contre l’asthme allergique
Press release
07.03.2023
A New Milestone in the Development of an Effective Allergic Asthma Vaccine
To combat allergic asthma, which affects millions of people worldwide, scientists from Inserm, CNRS and Université...
Asthmevaccinallergieneovacsbruhns
Press release
21.02.2023
A blood factor involved in depression
The process of aging is often related to the onset of cognitive decline, depression and memory loss. Scientists from...
neurology
Test LuLISA, plaque 384 avec des puits lumineux. Crédit : Institut Pasteur / Sophie Goyard
Press release
13.12.2022
Epidemics, pandemics: a never-ending story? – a look back at the conference held on December 7, 2022
In connection with the bicentenary of Louis Pasteur’s birth, a conference entitled "Epidemics, pandemics: a never-...
Institut Pasteur
Press Info
21.10.2022
SpikImm announces the clinical trials start for SPK001, its monoclonal antibody against SARS-CoV-2
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by...

Pages

Back to top